Virus Diseases Terminated Phase 2 Trials for Ribavirin (DB00811)

Also known as: Virus Disease

IndicationStatusPhase
DBCOND0028162 (Virus Diseases)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02613403Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)Treatment